| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | Sep 19, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,800 | -26.30% | ✗ | $747.8K |
| Nov 11, 2024 | Nov 12, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,750 | -23.63% | ✗ | $721.8K |
| Jun 17, 2024 | Jun 18, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,700 | -23.27% | ✗ | $502.2K |
| Jun 7, 2024 | Jun 10, 2024 | Ares Management Corp | Director | Sell | 20.0 | -3,417 | -11.12% | ✗ | $457.9K |
| May 3, 2024 | May 6, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -10,000 | -57.79% | ✗ | $2.6M |
| Mar 12, 2024 | Mar 13, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -5,000 | -40.63% | ✗ | $1.2M |
| May 23, 2023 | May 25, 2023 | Ares Management Corp | Director | Sell | 22.5 | -1,200 | -3.97% | ✗ | $102.7K |
| Jan 3, 2023 | Jan 3, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -1,150 | -15.02% | ✓ | $317.7K |
| Dec 9, 2022 | Dec 9, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,010 | -11.66% | ✗ | $284.8K |
| Nov 7, 2022 | Nov 8, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 22.5 | -1,725 | -16.60% | ✗ | $159.1K |
| Jun 27, 2022 | Jun 28, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 5.0 | -10,000 | -54.85% | ✓ | $2.4M |
| May 26, 2022 | May 26, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -10,000 | -54.85% | ✗ | $2.3M |
| Apr 1, 2021 | Apr 2, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -4,207 | -42.08% | ✓ | $778.1K |
| Mar 17, 2021 | Mar 19, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,103 | -26.64% | ✓ | $357.5K |
| Jun 8, 2020 | Jun 8, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -4,510 | -56.38% | ✗ | $563.6K |